Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CSTL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Castle Biosciences Inc

CSTL
Current price
19.66 USD -0.02 USD (-0.10%)
Last closed 19.84 USD
ISIN US14843C1053
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 572 826 432 USD
Yield for 12 month +4.30 %
1Y
3Y
5Y
10Y
15Y
CSTL
21.11.2021 - 28.11.2021

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a risk stratification spatial-omics test to predict future development of progression of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide optimal drug treatment for patients diagnosed with major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. The company offers its products to skin cancer and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas. Address: 505 S. Friendswood Drive, Friendswood, TX, United States, 77546

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

35.89 USD

P/E Ratio

Dividend Yield

Financials CSTL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+332 069 000 USD

Last Year

+219 788 000 USD

Current Quarter

+87 988 000 USD

Last Quarter

+86 311 000 USD

Current Year

+271 864 000 USD

Last Year

+174 806 000 USD

Current Quarter

+87 988 000 USD

Last Quarter

+70 128 000 USD
EBITDA 28 634 000 USD
Operating Margin TTM -31.74 %
Price to Earnings
Return On Assets TTM -1.80 %
PEG Ratio
Return On Equity TTM -1.20 %
Wall Street Target Price 35.89 USD
Revenue TTM 347 083 008 USD
Book Value 15.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 20.60 %
Dividend Yield
Gross Profit TTM 284 388 992 USD
Earnings per share -0.19 USD
Diluted Eps TTM -0.19 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -92.60 %
Profit Margin -1.46 %

Stock Valuation CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.96
Price Sales TTM 1.65
Enterprise Value EBITDA 8.13
Price Book MRQ 1.32

Technical Indicators CSTL

For 52 Weeks

15.45 USD 35.84 USD
50 Day MA 18.07 USD
Shares Short Prior Month 1 250 663
200 Day MA 24.63 USD
Short Ratio 3.05
Shares Short 1 598 757
Short Percent 4.96 %